The American Society of Breast Surgeons published new guidelines yesterday recommending that genetic testing should be made available to all patients with a history of breast cancer, spurring a debate about how genetic testing should be used in the future.
The recommendations are based on a December study that showed that existing guidelines by the National Comprehensive Cancer Network (NCCN) are too restrictive
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?